Know what's working.
Grovera shows families and clinicians what the evidence says about each intervention, and whether this child is actually changing.
Dozens of interventions, very different evidence, and progress that is rarely measured
Families hear about all of them. Clinicians rarely have time to check each one. Once a program starts, it is hard to tell whether it is helping this child.
Parents see the whole week. Clinicians see the visit.
Most change happens at home, at school and at the park. Grovera gives families a way to bring what they see into the plan, and gives clinicians the evidence to talk it through.
- 1Notice. A new way to ask for something, a calmer trip to the store, a routine that finally works.
- 2Ask. Look up what you read about online and bring plain-language questions to the next visit.
- 3Measure together. Parent-reported measures sit beside the clinician's standardized re-checks.
Four questions for every intervention
- 01 · Population evidenceDoes it work for children like this?Graded by outcome domain and by age and support needs.
- 02 · Dose evidenceWhat does the research say about how much?Evidence ranges and their uncertainty. Grovera never sets an hours limit.
- 03 · Individual evidenceIs this child changing?A baseline and regular standardized re-checks, read against measurement error.
- 04 · Harm and costWhat does it cost, and is there harm?Reported harms, evidence of no benefit, and the time and money involved.
Progress on what matters to this child
Grovera grades evidence by outcome domain, so a plan is judged on the goals a family cares about. Communication counts in any form: speech, sign or a device.
A measurement, read against its own error
Once a child has a baseline and a re-check, Grovera reports whether the change on a standardized measure is larger than the measure's own error. The calculation is deterministic; no language model is involved.
Who it is for
Grovera shows the evidence. You and the family decide.
How the evidence is graded →Early access for clinicians and centers
The first clinicians join through a pilot with US developmental centers in 2027.
- L1 · Shaw KA, et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years. MMWR Surveill Summ. 2025;74(2). ADDM Network, 2022 data.
- L2 · Danielson ML, et al. ADHD prevalence among U.S. children and adolescents in 2022. J Clin Child Adolesc Psychol. 2024.
- L3 · Steinbrenner JR, et al. Evidence-based practices for children, youth, and young adults with autism. National Clearinghouse on Autism Evidence and Practice, 2020. Literature 1990–2017.
- R1, R2, R3 · Placeholder source ids in the illustrative product screen.